Catalyst Funds Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-27,139	Closed	-$69.5K	–	649
2025 Q1	$69.5K	Buy	27,139 +16,939	+166%	+$43.4K	0.02%	402
2024 Q4	$19.2K	Hold	10,200	–	–	﹤0.01%	292
2024 Q3	$10.4K	Hold	10,200	–	–	﹤0.01%	1179
2024 Q2	$11.9K	Buy	+10,200	New	+$11.9K	﹤0.01%	866